Showing results (2101-2110 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|April 3, 2022
Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control studyThiago Cerqueira-Silva, Jason R Andrews, Viviane S Boaventura, et al.
The Lancet. Infectious Diseases|April 15, 2022
Whipple's disease and Tropheryma whipplei infections: from bench to bedsideAsma Boumaza, Eya Ben Azzouz, Jeffrey Arrindell, et al.
The Lancet. Infectious Diseases|May 5, 2022
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort studyNorbert Ndjeka, Jonathon R Campbell, Graeme Meintjes, et al.
The Lancet. Infectious Diseases|October 9, 2021
Migration and outbreaks of vaccine-preventable disease in Europe: a systematic reviewAnna Deal, Rae Halliday, Alison F Crawshaw, et al.
The Lancet. Infectious Diseases|October 10, 2021
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy studyAdam Penn-Nicholson, Sophia B Georghiou, Nelly Ciobanu, et al.
The Lancet. Infectious Diseases|January 30, 2022
Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, ItalyGiovanni Corrao, Matteo Franchi, Danilo Cereda, et al.
The Lancet. Infectious Diseases|March 18, 2022
Prevalence, incidence, and reported global distribution of noma: a systematic literature reviewAnaïs Galli, Curdin Brugger, Thomas Fürst, et al.
The Lancet. Infectious Diseases|March 20, 2022
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional studyDaniel J Sheward, Changil Kim, Roy A Ehling, et al.
The Lancet. Infectious Diseases|February 6, 2022
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling studyRuthie Birger, Marina Antillón, Joke Bilcke, et al.
The Lancet. Infectious Diseases|March 24, 2022
Individualised treatment of Mycoplasma genitalium infection-incorporation of fluoroquinolone resistance testing into clinical careEmma L Sweeney, Catriona S Bradshaw, Gerald L Murray, et al.
Pageof 270